LORAZEPAM vs LORLATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LORAZEPAM vs LORLATINIB: Safety Overview
| Metric | LORAZEPAM | LORLATINIB |
|---|---|---|
| Total FAERS Reports | 33,404 | 5,508 |
| Deaths Reported | 6,187 | 1,542 |
| Death Rate | 18.5% | 28.0% |
| Hospitalizations | 15,431 | 1,232 |
| Average Patient Age | 49.8 yrs | 56.5 yrs |
| % Female Patients | 60.8% | 54.0% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Nov 2, 2018 |
| Manufacturer | Hikma Pharmaceuticals USA Inc. | Pfizer Laboratories Div Pfizer Inc |
| Route | INTRAMUSCULAR | ORAL |
| Marketing Status | Prescription | Prescription |